Results 71 to 80 of about 44,133 (142)

Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study. [PDF]

J Clin Med, 2022
Alcaraz A, Castro-Díaz D, Gacci M, Salonia A, Ficarra V, Carballido-Rodríguez J, Rodríguez-Antolín A, Medina-Polo J, Fernández-Gómez JM, Cózar-Olmo JM, Búcar-Terrades S, Pérez-León N, Brenes-Bermúdez FJ, Molero-García JM, Fernández-Pro-Ledesma A, Herdman M, Angulo JC, Manasanch J, On Behalf Of The Qualiprost Study Group.   +18 more
europepmc   +1 more source

EFFECTIVENESS OF 5-ALPHA-REDUCTASE INHIBITORS IN PATIENTS WITH PROSTATIC INTRAEPITHELIAL NEOPLASIA OF PERIPHERAL PROSTATE ZONE

Східноукраїнський медичний журнал, 2019
Prostate intraepithelial neoplasia (PIN) is a widespread pathologic state, which in 16–25 % cases leads to prostate cancer (PC). Today specific operative and medicated methods of PIN treatment are not developed. The aim of PIN treatment represents at the
M. P. Мelnychuk
doaj  

Change in hair growth-related gene expression profile in human isolated hair follicles induced by 5-alpha reductase inhibitors - dutasteride and finasteride - in the presence of testosterone. [PDF]

Singapore Med J, 2022
Hatanaka T, Lulic Z, Mefo T, Booth C, Harrison E, Ong G.   +5 more
europepmc   +1 more source

446 THE EFFECT OF THE MEDICATIONS BY ALPHA-1 BLOCKERS AND 5 ALPHA REDUCTASE INHIBITORS FOR CHRONIC PROSTATIC INFLAMMATION.

Continence, 2022
S Inamura, T Shinagawa, H Kobayashi, M Tsutsumiuchi, M Seki, M Taga, M Fukushima, H Ito, M Kobayashi, O Yokoyama, N Terada   +10 more
doaj   +1 more source

The role of 5-alpha reductase inhibitors in transurethral resection of the prostate: a meta-analysis of randomised controlled trials. [PDF]

BJU Int
Hehir CM, Calpin GG, Cullivan O, Daly GR, Dowling GP, Davis NF.   +5 more
europepmc   +1 more source

May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications? [PDF]

Med Hypotheses, 2020
Adamowicz J, Juszczak K, Drewa T.
europepmc   +1 more source

Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study. [PDF]

Yonsei Med J
Nguyen MH, Ko J, Cho J.
europepmc   +1 more source

Effects of 5-alpha reductase inhibitors on lung function: A reason for discontinuation during COVID-19 pandemic? [PDF]

Dermatol Ther, 2020
Kroumpouzos G.
europepmc   +1 more source

Geographic Influence and Metabolomics-Driven Discovery of 5-Alpha Reductase Inhibitors in <i>Tectona grandis</i> L.f. (Teak) Leaves. [PDF]

Molecules
Tanuphol N, Girard C, Temkitthawon P, Suphrom N, Nuengchamnong N, Saesong T, Insumrong K, Wadeng A, Khangkhachit W, Zedet A, Intayot R, Jungsuttiwong S, Plubrukarn A, Senejoux F, Ingkaninan K.   +14 more
europepmc   +1 more source

An exploratory analysis of 5-alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications. [PDF]

Am J Addict
Tawfik AG, Lister T, Gomez-Lumbreras A, Peterson RT, Bortolato M, Malone DC.   +5 more
europepmc   +1 more source